← HEALTH CANADA RECALLS
HEALTH CANADA · HEALTH PRODUCTSAugust 15, 2026
Two lots of Teva-Pregabalin 150 mg capsules recalled due to cross-contamination with the drug sertraline
What this record is not
Recall details are published by Health Canada; SPEQ surfaces them for reference and is not affiliated with or endorsed by Health Canada. The authoritative notice is on recalls-rappels.canada.ca.
Category
Health products
Published
August 15, 2026
Regulator
Health Canada
What this signals · SPEQ interpretation
SPEQ reads this recall’s stated subject as touching contamination control and cleaning validation. That is a keyword reading of the published subject, not an official classification — the requirements and playbooks below are where a team would look to prevent or close it.
Requirements behind it
EU GMP Annex 1 (2022)Manufacture of Sterile Medicinal ProductsEU GMP Annex 15Qualification and Validation
Decode the practice
DisciplinesGMP
READ THE FULL NOTICE
The complete recall notice — the affected products, lots, and the hazard — is published by Health Canada. SPEQ surfaces and indexes it for reference; the authoritative notice lives on recalls-rappels.canada.ca.
View on canada.ca →